Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3507277 A
Publication typeGrant
Publication dateApr 21, 1970
Filing dateSep 15, 1967
Priority dateSep 17, 1966
Publication numberUS 3507277 A, US 3507277A, US-A-3507277, US3507277 A, US3507277A
InventorsAltounyan Roger Edward Colling, Howell Harry
Original AssigneeFisons Pharmaceuticals Ltd
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Inhalation device
US 3507277 A
Abstract  available in
Images(1)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

April 1970 R. E. c. ALTQOUINYAN ET AL 3,507,277

INHALATION DEVICE Filed Sept. 15, 1967 INVENTORS ROGER E.C. ALTOUNYAN HARRY HOWELL BY f y /g a ,2 z/ww' ATTORNEYS United States Patent 3,507,277 INHALATION DEVICE Roger Edward Collingwood Altounyan, Wilmslow, and Harry Howell, Castle Donnington, England, asslgnors to Fisons Pharmaceuticals Limited, Loughborough, Leicestershire, England Filed Sept. 15, 1967, Ser. No. 667,975 Claims priority, application Great Britain, Sept. 17, 1966,

. 41,595/ 66 Int. Cl. A61m 15/00, 15/08; B26f 1/24 U.S. Cl. 128208 6 Claims ABSTRACT OF THE DISCLOSURE A device for the oral inhalation of medicaments in finely divided form which comprises a hollow elongate housing having at both ends thereof one or more passageways to permit the passage of air and having one end thereof adapted for insertion into the mouth; and a propeller-like device rotatably mounted in the said housing on a rigid shaft mounted in said housing and co-axial with the longitudinal axis of the housing, said propellerlike device having, on the end thereof furthest from the end of the housing adapted for insertion in the mouth, mounting means adapted to receive a container for the finely divided medicament; which device is provided with means for perforating the container of medicament in situ in the device.

This invention is concerned with improvements in or relating to a device for the application of medicaments in finely divided form by oral inhalation.

More particularly the invention is concerned with a device for the oral inhalation of medicaments in finely divided form which comprises a hollow elongate housing, suitably a tubular housing, having at both ends thereof one or more passageways to permit the passage of air and having one end thereof adapted for insertion into the mouth; and a propeller-like device rotatably mounted in the said housing on a rigid shaft mounted in said housing and co-axial with the longitudinal axis of thehousing, said propeller-like device having, on the partthereof furtherest from the end of the housing adaptedQfor insertion in the mouth, mounting means adapted to receive a container for the finely divided medicament such as a gelatine or like capsule. (By the term propeller-like device is meant a device having two or more blades or vanes disposed about a central axis or hub, such that impingement of an air stream on the said vanes or blades tends to cause rotation of the device about said axis or hub.)

In order to dispense its contents the container of the finely powdered medicament must be perforated and it has been found very convenient to perforate the container in situ in the dispensing device.

According to the invention, therefore, there is provided a dispensing device of the type described provided with means for perforating the container of the finely powdered medicament in situ in the device.

The device according to the invention is particularly convenient since it may be carried by the user with the closed container already in place in the device and is simply used by actuating the container perforating means and then inhaling the contents of the container by inspiration through the device. Since the container is closed or sealed until it is desired to use the device there is no risk of contamination of the contents of the container and, in the case of medicament powders showing hydroscopic tendencies, there is no risk of caking of the medicament prior to use.

Suitably the container used in the device is a capsule, for example a gelatin capsule, and conveniently the capsule perforating means is so arranged to provide one or more holes, suitably of about 0.60.65 mm. in diameter, desirably in the part of the capsule furthest from the propeller-like device, advantageously in the shoulders of the capsule. Where the perforating means is so arranged as to provide two or more holes in the container, these are conveniently positioned symmetrically around the container.

Suitably, the container perforating means may take the form of one or more spring-loaded piercing pins mounted in the housing so that they are normally urged, by the springs, away from the container but which may be pressed inwards to perforate the container by the action of push buttons located on the exterior of the housing.

It has been found that, in order to obtain optimum perforation of a gelatin capsule, the perforating ends of the piercing pins should not be sharpened to a conventional conical point but should be sharpened with a plane face at an acute angle. Further, the acute angled plane face should desirably face away from propeller-like device.

It is desirable that the propeller-like device he so mounted upon the shaft that the passage of an air stream causes not only rotational movement of the propeller-like device but also a vibrational component of motion. This vibrational component of the motion has been found to contribute to the release of the powdered medicament from the capsule.

In order that the propeller-like device should be capable of undergoing vibrational movement, it has been found desirable that the bearing in the propeller-like device in which the shaft engages. should have certain dimensional characteristics. Thus the bearing takes the form of an elongate cavity of circular cross-section and the shaft is, of course, also of circular cross-section.

The internal diameter of the bearing at its inner end, i.e. the end housing the free end of the shaft, is desirably from 1.5% to 6% preferably 2.5 to 5%, e.g. 3.75% greater than the diameter of the shaft and the diameter of the hearing at its outer end is equal to the diameter of the shaft plus from 1.3 to 3.5% e.g. about 2.5% of the total length of the bearing. The actual length of the bearing is not critical but may be, for example, from 4 to 10 times the diameter of the shaft.

The inner end wall of the bearing is preferably flat and the end of the shaft which engages with it is suitably of frusto conical shape, preferably terminating in a hemispllliefrical portion e.g. of a radius of about half that of the s a t.

The shaft itself should be rigidly mounted since we have found that undue flexibility of the shaft and mounting causes malfunctioning of the device.

The device according to the invention is suit-able for the administration of medicaments for the alleviation of a lments of the bronchial tract and of the lungs. The device may also be used for the administration of medicaments having systemic action, for example it may be used for the administration of antidotes to poisonous substances such as nerve gases as it provides a very simple method of carrying medicaments which have to be used rapidly or in emergency.

In order that the invention may be well understood, one embodiment thereof will now be described with reference to the accompanying drawing which is a longitudinal crosssection through the device.

Referring now to the drawing, an inhalation device comprises a housing of approximately circular cross-section comprising two engaging members 1 and 2, housing 2 being adapted for insertion into the mouth and having passage- 3 ways 3 therein to permit the passage of air. Mounted rigidly in and co-axially with housing member 2 is shaft 4 upon which is loosely and rotatably mounted propeller-like device 5 having blades 6.

Propeller-like device 5 has a cup shaped member adapted to receive and hold a capsule or container of finely powdered medicament 7.

Shaft 4 engages in bearing 8 in propeller 5. The diameter at the inner end of bearing 8 is about 3.75% greater than the diameter of shaft 4 and the diameter at the outer end of bearing 8 is equal to the diameter of shaft 4 plus about 2.5% of the total length of the bearing, which is about 7 times the diameter of shaft 4.

The tip 9 of shaft 4 is conical in shape, having a cone angle of about 30, and terminates in a substantially hemispherical portion having a diameter of about half the diameter of shaft 4.

Housing member 1 has in its end wall air passages 10 to permit the passage of air and constricting member 11 which serves to constrict the air stream through the device and thus increase its velocity past the capsule.

Mounted on the outside of housing member 1 are two hollow projections 12 and 12a having slidably engaged therein push buttons 13 and 13a. Push buttons 13 and 13a are retained in projections 12 and 12a by means of pins 14 and 14a engaging in slots in the push buttons, and are urged outwardly from housing member 1 by means of springs 15 and 15a. Attached to push buttons 13 and 13a are piercing pins 16 and 16a. For purposes of illustration, one assembly is shown in the non-piercing position whereas the other assembly is shown with the tip of pin 16a having pierced capsule 7, push button 13a having been depressed against the action of spring 15a.

In operation, housing members 1 and 2 are separated and capsule 7 is loaded into propeller-like device 5. Housing members 1 and 2 are then clipped together again and the device is ready for use. In use, the user first depresses buttons 13 and 13a to cause pins 16 and 16a to pierce capsule 7. He then releases buttons 13 and 13a to remove pins 16 and 16a from the capsule and subsequently inhales through the device to obtain, by inhalation, the contents of capsule 7.

We claim:

1. A device for the oral inhalation of medicaments in finely divided form which comprises a hollow elongate housing having at both ends thereof at least one passageway to permit passage of air and one of said ends being adapted for insertion into the mouth of the user; a propellet means rotatably mounted in said housing on a rigid shaft secured in said housing and co-axial with the longitudinal axis of said housing, said propeller means having on its end furthest from said one end of said housing a mounting means for receiving a container of said finely divided medicaments; and means mounted on said housing for perforating said container While said container is mounted on said mounting means, said perforating means comprising at least one spring loaded piercing member mounted in said housing and having push button means attached thereto for pressing said piercing members into said container.

2. An inhalation device according to claim 1, further comprising a bearing engaging said shaft, said bearing having an internal diameter at its inner end from 1.5 to 6% greater than the diameter of said shaft and an internal diameter at its outer end equal to the diameter of said shaft plus from 1.3 to 3.5% of the total length of said bearing.

3. An inhalation device according to claim 1 in which the piercing members are provided with piercing points taking the form of a plane face at an acute angle to the axis of said member.

4. An inhalation device according to claim 2 in which the internal diameter of the bearing at its inner end is from 2.5 to 5% greater than said diameter of said shaft.

5. An inhalation device according to claim 2 in which the internal diameter of said bearing at its inner end is about 3.75% greater than the diameter of said shaft and said internal diameter of said hearing at its outer end is equal to the diameter of said shaft plus about 2.5 of the length of said bearing.

6. An inhalationdevice according to claim 1, further comprising a bearing engaging said shaft, the length of said bearing being from 4 to 10 times the diameter of said shaft.

References Cited UNITED STATES PATENTS 2,517,482 8/1950 Hall 128-206 2,573,918 11/1951 McCuiston 128206 ANTON 0. OESCHSLE, Primary Examiner P. E. SHAPIRO, Assistant Examiner US. Cl. X.R. 128206

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2517482 *Apr 9, 1949Aug 1, 1950Sharp & Dohme IncInhaler
US2573918 *Nov 5, 1949Nov 6, 1951Vick Chemical CompanyDevice for dispensing medicaments
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3635219 *Jun 4, 1969Jan 18, 1972Fisons Pharmaceuticals LtdInhalation device
US3795244 *Feb 2, 1973Mar 5, 1974Syntex CorpInhalation device
US3807400 *Jun 26, 1972Apr 30, 1974Isf SpaInhaling device for medicinal powder compositions
US3858583 *Jan 28, 1974Jan 7, 1975Allen & Hanburys LtdMedicament inhalation device
US3888253 *Jun 7, 1974Jun 10, 1975Beecham Group LtdDevice for administration of medicines
US3906950 *Apr 2, 1974Sep 23, 1975Isf SpaInhaling device for powdered medicaments
US3971377 *Jul 21, 1975Jul 27, 1976Alza CorporationMedicament dispensing process for inhalation therapy
US4098273 *Nov 5, 1976Jul 4, 1978Syntex Puerto Rico, Inc.Inhalation device
US4884565 *Jul 27, 1988Dec 5, 1989Miat S.P.A.Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola
US4889114 *Jul 2, 1987Dec 26, 1989Boehringer Ingelheim KgPowdered pharmaceutical inhaler
US5152284 *May 24, 1991Oct 6, 1992Phidea S.P.A.Disposable inhaler with pre-pierced capsule
US5327883 *May 20, 1991Jul 12, 1994Dura Pharmaceuticals, Inc.Apparatus for aerosolizing powdered medicine and process and using
US5337740 *Aug 1, 1991Aug 16, 1994New England Pharmaceuticals, Inc.Inhalation devices
US5492112 *Apr 14, 1994Feb 20, 1996Dura Pharmaceuticals, Inc.Dry powder inhaler
US5529059 *May 27, 1994Jun 25, 1996Sepracor Inc.Inhalation devices
US5577497 *Oct 14, 1993Nov 26, 1996Dura Pharmaceuticals, Inc.Dry powder inhaler
US5619985 *Aug 3, 1995Apr 15, 1997Unisia Jecs CorporationInhaler type medicine administering device
US5715810 *Jun 24, 1996Feb 10, 1998Sepracor Inc.Inhalation devices
US5724959 *Sep 16, 1994Mar 10, 1998Aea Technology PlcPowder inhaler with specific orifice and baffle arrangement
US6142146 *Jun 12, 1998Nov 7, 2000Microdose Technologies, Inc.Inhalation device
US6152130 *Jun 12, 1998Nov 28, 2000Microdose Technologies, Inc.Inhalation device with acoustic control
US6237591Nov 2, 1998May 29, 2001Dura Pharmaceuticals, Inc.Turbine dry powder inhaler
US6681768Jun 21, 2002Jan 27, 2004Sofotec Gmbh & Co. KgPowder formulation disintegrating system and method for dry powder inhalers
US6705313 *May 9, 2002Mar 16, 2004Ph&T S.P.A.Device usable in the treatment of affections of the airways
US7080644Jun 25, 2001Jul 25, 2006Microdose Technologies, Inc.Packaging and delivery of pharmaceuticals and drugs
US7318434Feb 17, 2005Jan 15, 2008Microdose Technologies, Inc.Synthetic jet based medicament delivery method and apparatus
US7334577Mar 1, 2006Feb 26, 2008Microdose Technologies, Inc.Synthetic jet based medicament delivery method and apparatus
US7669597May 15, 2008Mar 2, 2010Mystic Pharmaceuticals, Inc.Combination unit dose dispensing containers
US7779837Dec 6, 2007Aug 24, 2010Microdose Therapeutx, Inc.Synthetic jet based medicament delivery method and apparatus
US7810495Jun 19, 2006Oct 12, 2010Microdose Therapeutx, Inc.Packaging and delivery of pharmaceuticals and drugs
US7950390Aug 25, 2009May 31, 2011Microdose Therapeutx, Inc.Packaging and delivery of pharmaceuticals and drugs
US7963089Sep 15, 2008Jun 21, 2011Mystic Pharmaceuticals, Inc.Deep draw container forming method
US8322338May 7, 2010Dec 4, 2012Microdose Therapeutx, Inc.Synthetic jet based medicament delivery method and apparatus
US8357696Jan 28, 2010Jan 22, 2013Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8371294Feb 25, 2009Feb 12, 2013Microdose Therapeutx, Inc.Method and apparatus for driving a transducer of an inhalation device
US8377009Jan 9, 2008Feb 19, 2013Mystic Pharmaceuticals, Inc.Intranasal cartridge devices
US8439033Oct 6, 2008May 14, 2013Microdose Therapeutx, Inc.Inhalation device
US8474452Feb 23, 2005Jul 2, 2013Microdose Therapeutx, Inc.Directional flow sensor inhaler
US8524734Oct 22, 2009Sep 3, 2013Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8524735Oct 22, 2009Sep 3, 2013Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8546423Oct 22, 2009Oct 1, 2013Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US8573202Aug 17, 2010Nov 5, 2013Microdose Therapeutx, Inc.Packaging and delivery of pharmaceuticals and drugs
US8584669Apr 11, 2007Nov 19, 2013Boehringer Ingelheim International GmbhInhaler
US8629139Oct 6, 2009Jan 14, 2014Mpex Pharmaceuticals, Inc.Topical use of Levofloxacin for reducing lung inflammation
US8683995Sep 15, 2011Apr 1, 2014Mystic Pharmaceuticals, Inc.Dose dispensing containers
US8748488Mar 14, 2013Jun 10, 2014Microdose Therapeutx, Inc.Methods and compositions for administration of oxybutynin
US8763606May 21, 2010Jul 1, 2014Microdose Therapeutx, Inc.Rotary cassette system for dry powder inhaler
US8815838Oct 6, 2009Aug 26, 2014David C. GriffithAerosol fluoroquinolone formulations for improved pharmacokinetics
US8985101Mar 15, 2013Mar 24, 2015Microdose Therapeutx, Inc.Method and device for clamping a blister within a dry powder inhaler
US8991390Jan 5, 2011Mar 31, 2015Microdose Therapeutx, Inc.Inhalation device and method
US9119777Dec 27, 2012Sep 1, 2015Microdose Therapeutx, Inc.Methods and compositions for administration of oxybutynin
US9132246Apr 9, 2013Sep 15, 2015Microdose Therapeutx, Inc.Inhalation device
US9162031Jun 7, 2013Oct 20, 2015Microdose Therapeutx, Inc.Directional flow sensor inhaler
US9180263Jun 30, 2010Nov 10, 2015Microdose Therapeutx, Inc.Laboratory animal pulmonary dosing device
US9248076Apr 1, 2014Feb 2, 2016Mystic Pharmaceuticals, Inc.Dose dispensing containers
US20030131847 *May 9, 2002Jul 17, 2003Fabrizio NiccolaiDevice usable in the treatment of affections of the airways
US20040206350 *Nov 14, 2003Oct 21, 2004Nektar TherapeuticsAerosolization apparatus with non-circular aerosolization chamber
US20050158394 *Jan 6, 2005Jul 21, 2005Vectura LimitedDelivery of oral drugs
US20050172962 *Feb 3, 2005Aug 11, 2005Microdose Technologies, Inc.Blister pack for use with an inhalation device
US20050183724 *Feb 17, 2005Aug 25, 2005Microdose Technologies, Inc.Synthetic jet based medicament delivery method and apparatus
US20050183725 *Feb 23, 2005Aug 25, 2005Microdose Technologies, Inc.Directional flow sensor inhaler
US20060174869 *Mar 1, 2006Aug 10, 2006Gumaste Anand VSynthetic jet based medicament delivery method and apparatus
US20060237011 *Jun 19, 2006Oct 26, 2006Gumaste Anand VPackaging and delivery of pharmaceuticals and drugs
US20070051362 *Apr 25, 2005Mar 8, 2007Sullivan Timothy RMultiple unit dose drug delivery system
US20070240712 *Apr 4, 2007Oct 18, 2007Scott FlemingVariable dose inhalation device
US20080115784 *Dec 6, 2007May 22, 2008Gumaste Anand VSynthetic jet based medicament delivery method and apparatus
US20080163610 *Jan 5, 2007Jul 10, 2008Matthew Thomas BairdMethod and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
US20080177246 *Jan 9, 2008Jul 24, 2008First City TowerIntranasal Cartridge Devices
US20090071108 *Sep 15, 2008Mar 19, 2009Mystic Pharmaceuticals, Inc.Deep draw container forming method
US20090084379 *Oct 1, 2008Apr 2, 2009Baxter International Inc.Dry powder inhaler
US20090090361 *Oct 6, 2008Apr 9, 2009Anand GumasteInhalation device
US20090194105 *Apr 11, 2007Aug 6, 2009Jens BesselerInhaler
US20090217925 *Feb 25, 2009Sep 3, 2009Anand GumasteMethod and apparatus for driving a transducer of an inhalation device
US20090314288 *Dec 24, 2009Gumaste Anand VPackaging and delivery of pharmaceuticals and drugs
US20100037890 *Oct 22, 2009Feb 18, 2010Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US20100040560 *Feb 18, 2010Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US20100087386 *Oct 6, 2009Apr 8, 2010Mpex Pharmaceuticals, Inc.Topical use of levofloxacin for reducing lung inflammation
US20100087416 *Oct 6, 2009Apr 8, 2010Mpex Pharmaceuticals, Inc.Aerosol fluoroquinolone formulations for improved pharmacokinetics
US20100158957 *Jan 28, 2010Jun 24, 2010Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US20100166673 *Oct 22, 2009Jul 1, 2010Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
US20100229860 *Sep 16, 2010Gumaste Anand VSynthetic jet based medicament delivery method and apparatus
US20100294278 *May 21, 2010Nov 25, 2010Mosier Kent DRotary cassette system for dry powder inhaler
US20110000481 *Jun 30, 2010Jan 6, 2011Anand GumasteNebulizer for infants and respiratory compromised patients
US20110000482 *Jun 30, 2010Jan 6, 2011Anand GumasteLaboratory animal pulmonary dosing device
US20110030679 *Aug 17, 2010Feb 10, 2011Gumaste Anand VPackaging and delivery of pharmaceuticals and drugs
US20110162642 *Jul 7, 2011Akouka Henri MInhalation device and method
CN102836487A *Jun 21, 2011Dec 26, 2012北京万达创制科技有限公司Double-needle piercing type dry powder inhaler
EP1941868A2Feb 26, 2001Jul 9, 2008PharmaKodex LimitedImprovements in or relating to the delivery of oral drugs
EP2357015A2Apr 4, 2007Aug 17, 2011MicroDose Therapeutx, Inc.Variable dose inhalation device
EP2594272A2May 18, 2006May 22, 2013Mpex Pharmaceuticals, Inc.Aerosolized fluoroquinolones and uses thereof
WO1999064095A2Jun 14, 1999Dec 16, 1999Microdose Technologies IncMetering, packaging and delivery of pharmaceuticals and drugs
WO2002092154A1Apr 26, 2002Nov 21, 2002New England Pharm IncMetered dose delivery device for liquid and powder agents
WO2005081833A2Feb 17, 2005Sep 9, 2005Microdose Technologies IncSynthetic jet based medicament delivery method and apparatus
WO2007107160A1Mar 21, 2007Sep 27, 2007Bang & Olufsen Medicom AsInhaler flow channel
WO2015143012A1Mar 18, 2015Sep 24, 2015Infinity Pharmaceuticals, Inc.Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
WO2015179369A1May 19, 2015Nov 26, 2015Infinity Pharmaceuticals, Inc.Treatment of pulmonary or respiratory diseases by inhalation administration of pi3 kinase inhibitors
WO2016007356A1Jul 1, 2015Jan 14, 2016Microdose Therapeutx, Inc.Inhalation device
Classifications
U.S. Classification128/203.15, 128/203.21
International ClassificationA61M15/00
Cooperative ClassificationA61M2202/064, A61M2015/0033, A61M15/0028
European ClassificationA61M15/00C